Posted in | News | Industrial Robotics | Machine-Vision

AV&R Vision & Robotics Announces Participation in the 50th International Paris Air Show

AV&R Vision & Robotics will be present during the 50th International Paris Air Show Le Bourget which will be held in Paris on June 17th to June 23rd 2013. Come meet AV&R’s team in the Hall 3 - Canadian Pavilion at the booth C-80 - D-79.

 

 

Eric Beauregard, CEO of AV&R, will take part of the Canadian Press Conference which be held at the beginning of the week to make a major announcement. Two Quebec Ministers will also be on site for this announcement: Élaine Zakaïb, Minister for Industrial Policy and the Banque de développement économique du Québec and Nicolas Marceau, Minister of Finance and the Economy. Join them and attend this announcement!

Citations

Please use one of the following formats to cite this article in your essay, paper or report:

  • APA

    AV&R. (2022, July 11). AV&R Vision & Robotics Announces Participation in the 50th International Paris Air Show. AZoRobotics. Retrieved on July 05, 2025 from https://www.azorobotics.com/News.aspx?newsID=4155.

  • MLA

    AV&R. "AV&R Vision & Robotics Announces Participation in the 50th International Paris Air Show". AZoRobotics. 05 July 2025. <https://www.azorobotics.com/News.aspx?newsID=4155>.

  • Chicago

    AV&R. "AV&R Vision & Robotics Announces Participation in the 50th International Paris Air Show". AZoRobotics. https://www.azorobotics.com/News.aspx?newsID=4155. (accessed July 05, 2025).

  • Harvard

    AV&R. 2022. AV&R Vision & Robotics Announces Participation in the 50th International Paris Air Show. AZoRobotics, viewed 05 July 2025, https://www.azorobotics.com/News.aspx?newsID=4155.

Tell Us What You Think

Do you have a review, update or anything you would like to add to this news story?

Leave your feedback
(Logout)
Your comment type
Submit
What Big Pharma Isn’t Telling You About AI Labs

What Big Pharma Isn’t Telling You About AI Labs

How AI and robotics are reshaping pharmaceutical R&D—from automated labs and in silico drug design to the growing tensions around secrecy, transparency, and equitable access in healthcare innovation.

Thought Leaders

Newsletters you may be interested in

See all Newsletters »

Terms

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

Provide Feedback